医学
闭塞性动脉硬化
动脉疾病
动脉硬化
外科
严重肢体缺血
血管内治疗
心脏病学
血管疾病
动脉瘤
作者
S M Wang,Chih‐Chien Yao
出处
期刊:PubMed
日期:2016-08-01
卷期号:54 (8): 564-7
被引量:5
标识
DOI:10.3760/cma.j.issn.0529-5815.2016.08.002
摘要
Endovascular therapy has become the first-line strategy for most peripheral artery disease cases. Currently, many guidelines recommend endovascular therapy as the first choice for arteriosclerosis obliterans. Recently, drug-eluting stent and drug-coated balloon are available. The clinical outcomes have been greatly improved with the evolution of devices. However, the long-term outcomes of endovascular therapy for arteriosclerosis obliterans are still not satisfied. Many centers treat arteriosclerosis obliterans using endovascular therapy in appropriately. In this editorial, an evidence-based approach and some strategies will be discussed to standardize the endovascular treatment and improve the result of endovascular therapy for arteriosclerosis obliterans.
科研通智能强力驱动
Strongly Powered by AbleSci AI